NCT06922487 Assessment of Tiredness During Awake Resection of Intracerebral Tumors
| NCT ID | NCT06922487 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Skane |
| Condition | Brain Tumor Adult |
| Study Type | OBSERVATIONAL |
| Enrollment | 10 participants |
| Start Date | 2024-11-11 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10 participants in total. It began in 2024-11-11 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Occasional patients with intracranial tumors need to have a planned awakening during surgery to avoid major disability from the tumor resection. During the awake part of the surgery an increasing degree of tiredness is observed. For the surgeon to plan the resection knowledge of the degree and speed of tiredness/sleepiness evolution is important. The goal of this single center study is to use the "Karolinska Sleepiness Scale" during and after awake surgery for neurosurgical tumor resection to quantify the time available for surgical intervention. Participants are adults having planned surgery for open resection of intracranial tumor with a planned awakening for assessment during surgery. Participants will be asked to grade postoperative sleepiness using the "Karolinska Sleepiness Scale".
Eligibility Criteria
Inclusion Criteria: * Adult (\>18 years old) * Elective supra or infratentorial tumor resection via craniotomy * Surgical need for awake surgery * Cognitive function allowing informed consent. Exclusion Criteria: * Tumor resection without awake surgery * Morbid obesitas
Contact & Investigator
Malin Rundgren, MD, PhD
PRINCIPAL INVESTIGATOR
Anaesthesia and Intensive Care, Skane University hospital, Lund, Sweden
Frequently Asked Questions
Who can join the NCT06922487 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Brain Tumor Adult. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06922487 currently recruiting?
Yes, NCT06922487 is actively recruiting participants. Contact the research team at johan.smalander@skane.se for enrollment information.
Where is the NCT06922487 trial being conducted?
This trial is being conducted at Lund, Sweden.
Who is sponsoring the NCT06922487 clinical trial?
NCT06922487 is sponsored by Region Skane. The principal investigator is Malin Rundgren, MD, PhD at Anaesthesia and Intensive Care, Skane University hospital, Lund, Sweden. The trial plans to enroll 10 participants.